Zylox-Tonbridge Repurchases 100,000 H-Shares for HK$2.38 Million, Lifting Treasury Stock to 7.30 Million Shares

Bulletin Express03-26 17:42

Zylox-Tonbridge Medical Technology Co., Ltd. (abbr. Zylox-Tonbridge) reported a share buyback on 26 March 2026 involving 100,000 H-shares executed on the Hong Kong Stock Exchange.

The company paid a volume-weighted average price of HK$23.84 per share (high: HK$24.52; low: HK$23.56), bringing total cash outlay for the repurchase to HK$2.38 million. All repurchased shares were retained as treasury shares.

Key capital metrics after the transaction: • Issued shares outstanding (excluding treasury shares) declined by 0.03 % to 329.05 million. • Treasury share balance increased to 7.30 million. • Total issued shares remained unchanged at 336.35 million.

Mandate utilisation: • The 30 May 2025 general mandate authorises Zylox-Tonbridge to buy back up to 31.96 million shares. • Cumulative repurchases under this mandate now total 4.49 million shares, equal to 1.37 % of the issued share base when the mandate was granted.

Pursuant to Hong Kong listing rules, Zylox-Tonbridge is restricted from issuing, selling, or transferring treasury shares until 25 April 2026. The board confirmed that the repurchase was conducted in compliance with all applicable regulations and that requisite funds have been fully settled.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160243443?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160243443","market":"us","top_or_hot":-1,"title":"Zylox-Tonbridge Repurchases 100,000 H-Shares for HK$2.38 Million, Lifting Treasury Stock to 7.30 Million Shares","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (abbr. Zylox-Tonbridge) reported a share buyback on 26 March 2026 involving 100,000 H-shares executed on the Hong Kong Stock Exchange.</p>\n<p>The company paid a volume-weighted average price of HK$23.84 per share (high: HK$24.52; low: HK$23.56), bringing total cash outlay for the repurchase to HK$2.38 million. All repurchased shares were retained as treasury shares.</p>\n<p>Key capital metrics after the transaction:\n• Issued shares outstanding (excluding treasury shares) declined by 0.03 % to 329.05 million.  \n• Treasury share balance increased to 7.30 million.  \n• Total issued shares remained unchanged at 336.35 million.</p>\n<p>Mandate utilisation:\n• The 30 May 2025 general mandate authorises Zylox-Tonbridge to buy back up to 31.96 million shares.  \n• Cumulative repurchases under this mandate now total 4.49 million shares, equal to 1.37 % of the issued share base when the mandate was granted.</p>\n<p>Pursuant to Hong Kong listing rules, Zylox-Tonbridge is restricted from issuing, selling, or transferring treasury shares until 25 April 2026. The board confirmed that the repurchase was conducted in compliance with all applicable regulations and that requisite funds have been fully settled.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Repurchases 100,000 H-Shares for HK$2.38 Million, Lifting Treasury Stock to 7.30 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Repurchases 100,000 H-Shares for HK$2.38 Million, Lifting Treasury Stock to 7.30 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-26 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (abbr. Zylox-Tonbridge) reported a share buyback on 26 March 2026 involving 100,000 H-shares executed on the Hong Kong Stock Exchange.</p>\n<p>The company paid a volume-weighted average price of HK$23.84 per share (high: HK$24.52; low: HK$23.56), bringing total cash outlay for the repurchase to HK$2.38 million. All repurchased shares were retained as treasury shares.</p>\n<p>Key capital metrics after the transaction:\n• Issued shares outstanding (excluding treasury shares) declined by 0.03 % to 329.05 million.  \n• Treasury share balance increased to 7.30 million.  \n• Total issued shares remained unchanged at 336.35 million.</p>\n<p>Mandate utilisation:\n• The 30 May 2025 general mandate authorises Zylox-Tonbridge to buy back up to 31.96 million shares.  \n• Cumulative repurchases under this mandate now total 4.49 million shares, equal to 1.37 % of the issued share base when the mandate was granted.</p>\n<p>Pursuant to Hong Kong listing rules, Zylox-Tonbridge is restricted from issuing, selling, or transferring treasury shares until 25 April 2026. The board confirmed that the repurchase was conducted in compliance with all applicable regulations and that requisite funds have been fully settled.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1160243443","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160243443","pubTimestamp":1774518137,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (abbr. Zylox-Tonbridge) reported a share buyback on 26 March 2026 involving 100,000 H-shares executed on the Hong Kong Stock Exchange. The company paid a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"Zylox-Tonbridge以238万港元回购10万股H股库存股增至730万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (abbr. Zylox-Tonbridge) reported a share buyback on 26 March 2026 involving 100,000 H-shares executed on the Hong Kong Stock Exchange.\nThe company paid a volume-weighted average price of HK$23.84 per share (high: HK$24.52; low: HK$23.56), bringing total cash outlay for the repurchase to HK$2.38 million. All repurchased shares were retained as treasury shares.\nKey capital metrics after the transaction:\n• Issued shares outstanding (excluding treasury shares) declined by 0.03 % to 329.05 million.  \n• Treasury share balance increased to 7.30 million.  \n• Total issued shares remained unchanged at 336.35 million.\nMandate utilisation:\n• The 30 May 2025 general mandate authorises Zylox-Tonbridge to buy back up to 31.96 million shares.  \n• Cumulative repurchases under this mandate now total 4.49 million shares, equal to 1.37 % of the issued share base when the mandate was granted.\nPursuant to Hong Kong listing rules, Zylox-Tonbridge is restricted from issuing, selling, or transferring treasury shares until 25 April 2026. The board confirmed that the repurchase was conducted in compliance with all applicable regulations and that requisite funds have been fully settled.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160243443","isCrawlerRequest":true}